FGF9, fibroblast growth factor 9, 2254

N. diseases: 153; N. variants: 2
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0349204
Disease: Nonorganic psychosis
Nonorganic psychosis
0.020 AlteredExpression disease BEFREE Clinical outcomes at 12 months were evaluated for transition to psychosis using the Comprehensive Assessment of At-Risk Mental States criteria, and the level of overall functioning was measured through the Global Assessment of Functioning [GAF] scale. 31722018 2019
CUI: C0349204
Disease: Nonorganic psychosis
Nonorganic psychosis
0.020 Biomarker disease BEFREE GAF and Cannon-Spoor scales were used to measure social functioning before and after onset of psychosis. 30099276 2018